Cargando…
Investigating the potential clinical significance of long non-coding RNA 00092 in patients with breast cancer
BACKGROUND: Aberrant promoter methylation and its resultant aberrant gene expression are important epigenetic mechanisms that promote the development of breast cancer (BC). However, the prognostic value of this type of methylation-driven gene in BC is unknown. METHODS: To identify DNA methylation-dr...
Autores principales: | Li, Jingquan, Lu, Fanghao, Shao, Xin, You, Bosen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201173/ https://www.ncbi.nlm.nih.gov/pubmed/35722403 http://dx.doi.org/10.21037/atm-22-1956 |
Ejemplares similares
-
5-FU@DHA-UIO-66-NH(2) potentiates chemotherapy sensitivity of breast cancer cells through a microRNA let-7a-dependent mechanism
por: Li, Jingquan, et al.
Publicado: (2021) -
LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway
por: Chen, Wei, et al.
Publicado: (2022) -
Lower expression of LINC00092 in lung adenocarcinoma might mean poorer prognosis: A study based on data mining and bioinformatics
por: Wang, Xin, et al.
Publicado: (2020) -
The oncogenic potentials and diagnostic significance of long non‐coding RNA LINC00310 in breast cancer
por: Li, Juan, et al.
Publicado: (2018) -
LINC00092 Suppresses the Malignant Progression of Breast Invasive Ductal Carcinoma Through Modulating SFRP1 Expression by Sponging miR-1827
por: Zhao, Chun-Ming, et al.
Publicado: (2022)